Navigation Links
PDI Reports 2012 Third Quarter Financial Results
Date:11/5/2012

PARSIPPANY, N.J., Nov. 5, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the third quarter ended September 30, 2012. Summary of third quarter and subsequent financial and operating highlights include:

  • Signed multi-year Sales Services contract valued at up to $150 million with Top 5 global pharmaceutical company.
  • Gerald J. Melillo promoted to President, Sales Services.
  • Condensed Summary Statement of Continuing Operations 3rd Quarter EndedNine Months EndedSeptember 30,*September 30,*2012201120122011Revenue, net$ 31,781$ 36,069$ 91,267$ 119,008Gross profit5,9397,67519,87523,770Operating expenses:Compensation expense4,0754,17112,72615,150Other SG&A2,6203,3098,44210,885Total operating expenses6,6957,48021,16826,035Operating (loss) income$ (756)$ 195$ (1,293)$ (2,265)Other expense, net-(48)(15)(122)Provision (benefit) for income tax74183219(512)Loss from continuing operations$ (830)$ (36)$ (1,527)$ (1,875)Diluted loss per share from continuing operations$ (0.06)$ -$ (0.10)$ (0.13)*Unaudited 

    CEO Comments
    Commenting on the company's results, Nancy Lurker, chief executive officer of PDI, Inc., noted, "As expected, third quarter revenue was below that of the same period in 2011 due primarily to the timing and implementation of new contracts. To date, we have won more than $250 million of new contracts and renewals in 2012. Due to the timing of these wins and the execution timelines of these contracts, we expect that only approximately $40 million will impact revenue in 2012. Factoring in this activity, we now estimate that total revenue for the full year of 2012 will be in the range of $127 - $130 million. 

    "Gross margins on our new Sales Services business in 2012 continue to trend lower than historical rates, including the $150 million win announced recently. We expect the gros
    '/>"/>

    SOURCE PDI, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    2. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    3. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    4. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    5. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    6. Pharmasset Reports Fiscal Year End 2011 Financial Results
    7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    8. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
    9. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
    10. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    11. Biodel Reports Fourth Quarter Fiscal Year 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... The global ... of 7.52% from 2015 to 2020. The bioscience market is expected to grow at ... increased use of failure analysis equipment in the research labs and academic institutions for ...
    (Date:7/2/2015)... ... July 03, 2015 , ... Cuvettes have been used in countless labs for decades. In ... cuvette they needed. As expected, this was a daunting and tiring process looking at ... they were not able to navigate the complex catalog structure. , Now thanks to FireflySci, ...
    (Date:7/2/2015)... Memphis, TN (PRWEB) , ... July 02, 2015 ... ... in the development and manufacturing of surgical instruments in Orthopedics, announced today the ... orthopedic contract-manufacturing and the world's largest provider of surgical instruments to the Spine ...
    (Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
    Breaking Biology Technology:Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5New Cuvette E-Commerce Website Launched by FireflySci 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
    ... PCR system, developed for,highfidelity PCR , , Kirk ... Daniel McMullan,* Barbara McGowan * Holly Hogrefe ,Stratagene Cloning ... the TaqPlus Precision PCR system,* to an expanding line ... a novel mixture of Taq2000 and Pfu DNA polymerases ...
    ... tools for neuroscience researchers , , Robert ... Browning, Mary Ellen Simcox ,Stratagene Cloning Systems, Inc. ... sets for the rat and human,NMDA receptor. In ... reverse,transcriptase-mediated polymerase chain reaction (RT-PCR) assays to show,expression ...
    ... ,Over 40% of Stratagenes GeneConnection cDNA gene clusters are ... full-length clones , Jason Goncalves Jean-Michel Lelias ... clone collection YY ,goes beyond normal ... tissues and has identified thousands of cDNAs that are ...
    Cached Biology Technology:High-Fidelity PCR with a Novel Polymerase Mixture 2High-Fidelity PCR with a Novel Polymerase Mixture 3High-Fidelity PCR with a Novel Polymerase Mixture 4High-Fidelity PCR with a Novel Polymerase Mixture 5High-Fidelity PCR with a Novel Polymerase Mixture 6High-Fidelity PCR with a Novel Polymerase Mixture 7High-Fidelity PCR with a Novel Polymerase Mixture 8High-Fidelity PCR with a Novel Polymerase Mixture 9High-Fidelity PCR with a Novel Polymerase Mixture 10High-Fidelity PCR with a Novel Polymerase Mixture 11Gene-Specific Primers for NMDA Receptor Subunits 2Gene-Specific Primers for NMDA Receptor Subunits 3Gene-Specific Primers for NMDA Receptor Subunits 4The GeneZoo or the GeneJungle? 2The GeneZoo or the GeneJungle? 3The GeneZoo or the GeneJungle? 4The GeneZoo or the GeneJungle? 5The GeneZoo or the GeneJungle? 6The GeneZoo or the GeneJungle? 7The GeneZoo or the GeneJungle? 8The GeneZoo or the GeneJungle? 9The GeneZoo or the GeneJungle? 10
    (Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
    (Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
    (Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
    Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
    ... University scientists have unveiled a revolutionary new technology that ... The new "solar steam" method from Rice,s Laboratory for ... steam from icy cold water. Details of the ... ACS Nano . The technology has an overall energy ...
    ... 2012 (Toronto) - The Centre for Addiction and ... psychiatrist Dr. Aristotle Voineskos, Koerner New Scientist and head ... the Campbell Family Mental Health Research Institute, has been ... Prize for university research in Ontario. The Polanyi ...
    ... of light to a chunk of gray matter smaller than ... and engineers at the Massachusetts Institute of Technology (MIT) in ... of light to a 3-D section of living brain tissue. ... but promising technique that uses gene therapy to turn individual ...
    Cached Biology News:Rice unveils super-efficient solar-energy technology 2Rice unveils super-efficient solar-energy technology 3CAMH scientist wins Polanyi Prize 2A 3-D light switch for the brain 2A 3-D light switch for the brain 3A 3-D light switch for the brain 4
    ...
    ... rapidly and reliably amplify unknown genomic DNA ... provides hassle-free, ready-to use components, at an ... provided in each kit. The BAC End ... amplification of large clones such as P1, ...
    No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
    Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
    Biology Products: